Dr @andreafava presents their noninvasive biomarker panel that predicted the probability of histologically active LN.
Tweet Content
Dr @andreafava presents their noninvasive biomarker panel that predicted the probability of histologically active LN.
Panel outperformed UPCR, C3, C4 & antidsDNA.
Aid in clinical-decision making? Lots of potential for monitoring tx response.
@Rheumnow #ACR24 abs1642
#ACRbest https://t.co/C7ZNdvbIQ7
Links
Show on Archive Page
On
Display in Search Results
On
PDQ
Off